Cargando…

Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015

BACKGROUND. Kano State, Nigeria, introduced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in March 2015 and was the pilot site for an RI data module for the National Health Management Information System (NHMIS). We determined factors impacting IPV introduction and the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Osadebe, Lynda U., MacNeil, Adam, Elmousaad, Hashim, Davis, Lora, Idris, Jibrin M., Haladu, Suleiman A., Adeoye, Olorunsogo B., Nguku, Patrick, Aliu-Mamudu, Uneratu, Hassan, Elizabeth, Vertefeuille, John, Bloland, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844228/
https://www.ncbi.nlm.nih.gov/pubmed/28838186
http://dx.doi.org/10.1093/infdis/jix044
_version_ 1783305217397227520
author Osadebe, Lynda U.
MacNeil, Adam
Elmousaad, Hashim
Davis, Lora
Idris, Jibrin M.
Haladu, Suleiman A.
Adeoye, Olorunsogo B.
Nguku, Patrick
Aliu-Mamudu, Uneratu
Hassan, Elizabeth
Vertefeuille, John
Bloland, Peter
author_facet Osadebe, Lynda U.
MacNeil, Adam
Elmousaad, Hashim
Davis, Lora
Idris, Jibrin M.
Haladu, Suleiman A.
Adeoye, Olorunsogo B.
Nguku, Patrick
Aliu-Mamudu, Uneratu
Hassan, Elizabeth
Vertefeuille, John
Bloland, Peter
author_sort Osadebe, Lynda U.
collection PubMed
description BACKGROUND. Kano State, Nigeria, introduced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in March 2015 and was the pilot site for an RI data module for the National Health Management Information System (NHMIS). We determined factors impacting IPV introduction and the value of the RI module on monitoring new vaccine introduction. METHODS. Two assessment approaches were used: (1) analysis of IPV vaccinations reported in NHMIS, and (2) survey of 20 local government areas (LGAs) and 60 associated health facilities (HF). RESULTS. By April 2015, 66% of LGAs had at least 20% of HFs administering IPV, by June all LGAs had HFs administering IPV and by July, 91% of the HFs in Kano reported administering IPV. Among surveyed staff, most rated training and implementation as successful. Among HFs, 97% had updated RI reporting tools, although only 50% had updated microplans. Challenges among HFs included: IPV shortages (20%), hesitancy to administer 2 injectable vaccines (28%), lack of knowledge on multi-dose vial policy (30%) and age of IPV administration (8%). CONCLUSION. The introduction of IPV was largely successful in Kano and the RI module was effective in monitoring progress, although certain gaps were noted, which should be used to inform plans for future vaccine introductions.
format Online
Article
Text
id pubmed-5844228
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58442282018-07-01 Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015 Osadebe, Lynda U. MacNeil, Adam Elmousaad, Hashim Davis, Lora Idris, Jibrin M. Haladu, Suleiman A. Adeoye, Olorunsogo B. Nguku, Patrick Aliu-Mamudu, Uneratu Hassan, Elizabeth Vertefeuille, John Bloland, Peter J Infect Dis Supplement Article BACKGROUND. Kano State, Nigeria, introduced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in March 2015 and was the pilot site for an RI data module for the National Health Management Information System (NHMIS). We determined factors impacting IPV introduction and the value of the RI module on monitoring new vaccine introduction. METHODS. Two assessment approaches were used: (1) analysis of IPV vaccinations reported in NHMIS, and (2) survey of 20 local government areas (LGAs) and 60 associated health facilities (HF). RESULTS. By April 2015, 66% of LGAs had at least 20% of HFs administering IPV, by June all LGAs had HFs administering IPV and by July, 91% of the HFs in Kano reported administering IPV. Among surveyed staff, most rated training and implementation as successful. Among HFs, 97% had updated RI reporting tools, although only 50% had updated microplans. Challenges among HFs included: IPV shortages (20%), hesitancy to administer 2 injectable vaccines (28%), lack of knowledge on multi-dose vial policy (30%) and age of IPV administration (8%). CONCLUSION. The introduction of IPV was largely successful in Kano and the RI module was effective in monitoring progress, although certain gaps were noted, which should be used to inform plans for future vaccine introductions. Oxford University Press 2017-07-01 2017-07-01 /pmc/articles/PMC5844228/ /pubmed/28838186 http://dx.doi.org/10.1093/infdis/jix044 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/3.0/igo This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Osadebe, Lynda U.
MacNeil, Adam
Elmousaad, Hashim
Davis, Lora
Idris, Jibrin M.
Haladu, Suleiman A.
Adeoye, Olorunsogo B.
Nguku, Patrick
Aliu-Mamudu, Uneratu
Hassan, Elizabeth
Vertefeuille, John
Bloland, Peter
Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title_full Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title_fullStr Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title_full_unstemmed Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title_short Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
title_sort assessing inactivated polio vaccine introduction and utilization in kano state, nigeria, april–november 2015
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844228/
https://www.ncbi.nlm.nih.gov/pubmed/28838186
http://dx.doi.org/10.1093/infdis/jix044
work_keys_str_mv AT osadebelyndau assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT macneiladam assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT elmousaadhashim assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT davislora assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT idrisjibrinm assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT haladusuleimana assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT adeoyeolorunsogob assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT ngukupatrick assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT aliumamuduuneratu assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT hassanelizabeth assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT vertefeuillejohn assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015
AT blolandpeter assessinginactivatedpoliovaccineintroductionandutilizationinkanostatenigeriaaprilnovember2015